Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 6Phase 3 3Phase 1 2Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1

Status

Completed 27Unknown 4Terminated 3Recruiting 3Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 261Breast 183Thoracic 170Genitourinary 132Head & Neck 99Lymphoid 91Gynecologic 80Other hematologic neoplasm 70CNS 48Plasma cell 44Dermatologic 28Sarcoma 21Tumor-Agnostic 16Other solid neoplasm 15Endocrine 14Myeloid 13NET 12Classical hematology 9Other neoplasm 3Other 3

Conditions

Skin Diseases 2Precancerous Conditions 2Keratosis, Actinic 2Venentoclax 1

Interventions

Aminolevulinic Acid 2venetoclax 1fludarabine 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Other neoplasm × Clear all
NCT07144345 2026-04-22

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

Sun Pharmaceutical Industries Limited

Phase 3 Recruiting
160 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT07144852 2026-04-22

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

Sun Pharmaceutical Industries Limited

Phase 3 Recruiting
260 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT07396480 2026-03-17

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial

First Affiliated Hospital of Zhejiang University

Phase 3 Recruiting
186 enrolled
Other neoplasm

Venentoclax

Data powered by HemOnc (CC BY 4.0) Colophon âš¡